HealthCap is the famous VC, which was founded in 1996. The main department of described VC is located in the Stockholm. The venture was found in Europe in Sweden.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the HealthCap, startups are often financed by HBM Healthcare Investments AG, Alta Partners, Johnson & Johnson Development Corporation. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, Industrifonden, Apax Partners. In the next rounds fund is usually obtained by Industrifonden, HBM Healthcare Investments AG, Sofinnova Partners.
Opposing the other organizations, this HealthCap works on 2 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2005. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. When the investment is from HealthCap the average startup value is 5-10 millions dollars. The increased amount of exits for fund were in 2015.
We also calculated 6 valuable employees in our database.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Algeta, Pulmonx, Fusion Pharmaceuticals We can highlight the next thriving fund investment areas, such as Manufacturing, Health Care. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 4 of the founder, the chance for it to get the investment is meager.
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ADCendo | $18M | 29 May 2024 | Copenhagen, Capital Region of Denmark, Denmark | ||
SynOx Therapeutics | $75M | 22 Apr 2024 | Dublin, Dublin, Ireland | ||
Aro Biotherapeutics | $41M | 28 Nov 2023 | Philadelphia, Pennsylvania, United States | ||
Rampart Bioscience | $85M | 24 Oct 2023 | La Jolla, California, United States | ||
HelloBetter | $8M | 03 May 2023 | Berlin, Berlin, Germany | ||
ADCendo | $36M | 04 Apr 2023 | Copenhagen, Capital Region of Denmark, Denmark | ||
Hemab | $135M | 21 Feb 2023 | Copenhagen, Capital Region of Denmark, Denmark | ||
Carisma Therapeutics | $30M | 21 Sep 2022 | Philadelphia, Pennsylvania, United States | ||
Pretzel Therapeutics | $72M | 12 Sep 2022 | Waltham, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ADCendo | $18M | 29 May 2024 | Copenhagen, Capital Region of Denmark, Denmark | ||
SynOx Therapeutics | $75M | 22 Apr 2024 | Dublin, Dublin, Ireland | ||
Aro Biotherapeutics | $41M | 28 Nov 2023 | Philadelphia, Pennsylvania, United States | ||
Rampart Bioscience | $85M | 24 Oct 2023 | La Jolla, California, United States | ||
HelloBetter | $8M | 03 May 2023 | Berlin, Berlin, Germany | ||
ADCendo | $36M | 04 Apr 2023 | Copenhagen, Capital Region of Denmark, Denmark | ||
Hemab | $135M | 21 Feb 2023 | Copenhagen, Capital Region of Denmark, Denmark | ||
Carisma Therapeutics | $30M | 21 Sep 2022 | Philadelphia, Pennsylvania, United States | ||
Pretzel Therapeutics | $72M | 12 Sep 2022 | Waltham, Massachusetts, United States |